Moreover, tumor CCT6A high expression was associated with lymph node metastasis (P = 0.001), elevated TNM stage (P = 0.002), and abnormal carcinoembryonic antigen (P = 0.022). Here, CCT6A is linked to metastatic malignant neoplasm in the lymph nodes.